[Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation]
- PMID: 8291289
[Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation]
Abstract
Programmable implantable cardioverter-defibrillators (ICD) with low energy capabilities for the treatment of ventricular tachycardia were introduced to increase patients acceptance and lengthen battery life. However, no data about efficacy and safety of low energy cardioversion with subsequent defibrillation in ventricular tachycardia and fibrillation are available. Nineteen of 42 patients with documented or inducible ventricular tachycardia before ICD implantation were studied. In all patients the effectiveness of low-energy cardioversion (< or = 4 joules) with subsequent high-energy defibrillation was evaluated in monomorphic ventricular tachycardia and/or ventricular fibrillation. During predischarge programmed stimulation in 13/19 patients, a total of 32 monomorphic ventricular tachycardias occurred, and in only six patients could ventricular fibrillation be induced. A tachycardia-related efficacy of 69% and patient-related efficacy of 46% of the low-energy cardioversion < or = 4 joules was observed. Ten tachycardias were accelerated to ventricular fibrillation or remained unchanged (n = 2). The second shock (energy > 17 joules) terminated seven arrhythmias, whereas a third (30 joules) shock or an external defibrillation (n = 2) was necessary for termination of the remaining three arrhythmias. After induction of ventricular fibrillation as the primary arrhythmia, the first (low-energy) shock terminated 2/16 episodes, whereas the second (high-energy) shock reverted ventricular fibrillation in 11/16 episodes. In one patient, a second high energy shock and in two patients external defibrillation was necessary for conversion of ventricular fibrillation. In one patient, an increase of the defibrillation threshold induced by amiodarone could be identified.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.J Am Coll Cardiol. 1996 Aug;28(2):400-10. J Am Coll Cardiol. 1996. PMID: 8800117 Clinical Trial.
-
[Shock-induced, but not terminated ventricular tachycardia in a patient with implantable defibrillator].Z Kardiol. 1996 May;85(5):306-11. Z Kardiol. 1996. PMID: 8711942 German.
-
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).Circulation. 2007 May 8;115(18):2382-9. doi: 10.1161/CIRCULATIONAHA.106.663112. Epub 2007 Apr 30. Circulation. 2007. PMID: 17470697 Clinical Trial.
-
[The implantable automatic cardioverter-defibrillator].Herz. 1990 Apr;15(2):111-25. Herz. 1990. PMID: 2188891 Review. German.
-
[Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].J Cardiol. 2000 Mar;35 Suppl 1:75-84. J Cardiol. 2000. PMID: 10834174 Review. Japanese.
Cited by
-
Ventricular fibrillation induced by high-output ICD shock: report of cases and review of literature.BMJ Case Rep. 2017 Jul 13;2017:bcr2017220098. doi: 10.1136/bcr-2017-220098. BMJ Case Rep. 2017. PMID: 28705844 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Medical